| AASLD

Issue Information

Read more about Issue Information

1 March 2019

Screening Strategies for Hepatitis C Virus

Read more about Screening Strategies for Hepatitis C Virus

Aaron G. Lim, Adam Trickey, Peter Vickerman – 1 March 2019

Letter to the Editor: Hypotheses and Assumptions in Mendelian Randomization: Proceed With Caution

Read more about Letter to the Editor: Hypotheses and Assumptions in Mendelian Randomization: Proceed With Caution

Christopher J. Danford, Ghideon Ezaz – 1 March 2019

Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal–Regulating Kinase 1 Pathways

Read more about Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal–Regulating Kinase 1 Pathways

Zhen Huang, Lei‐Ming Wu, Jie‐Lei Zhang, Abdelkarim Sabri, Shou‐Jun Wang, Gui‐Jun Qin, Chang‐Qing Guo, Hong‐Tao Wen, Bin‐Bin Du, Dian‐Hong Zhang, Ling‐Yao Kong, Xin‐Yu Tian, Rui Yao, Ya‐Peng Li, Cui Liang, Peng‐Cheng Li, Zheng Wang, Jin‐Yan Guo, Ling Li, Jian‐Zeng Dong, Yan‐Zhou Zhang – 1 March 2019 – Nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease worldwide. Due to the growing economic burden of NAFLD on public health, it has become an emergent target for clinical intervention.